تقرير
MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
| العنوان: | MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas |
|---|---|
| المصدر: | Phase II Trial of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas |
| الوصول الحر: | https://clinicaltrials.gov/ct2/show/NCT02407405Test |
| Other URLs: | https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_2016-C-0043.htmlTest |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |